JEFFREY D CAPELLO
CIK 1224108 · EVP & Chief Financial Officer · last filed 2025-10-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.10M
Companies
7
Total Filings
64
Lifetime Open-Market Net
-$13.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEOG | Director | 32,502 | $9.10 | $295.8K | $100.2K | 10 | 2025-10-29 |
| AGIO | Director | 6,073 | $29.46 | $178.9K | $0 | 5 | 2025-06-23 |
| BIIB | EVP & Chief Financial Officer | 3,118 | $200.05 | $623.8K | $0 | 5 | 2020-02-14 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | — | — | — | $0 | 5 | 2018-07-06 |
| Salarius Pharmaceuticals, Inc. (FLKS) Delisted | Director | — | — | — | $0 | 3 | 2017-07-27 |
| BOSTON SCIENTIFIC CORP (BSXw) Delisted | EVP & Chief Financial Officer | 447 | — | — | -$12.60M | 30 | 2013-12-02 |
| REVVITY, INC. (PKI) Delisted | SVP & CFO | 91,428 | $115.24 | $10.54M | -$989.9K | 4 | 2008-01-31 |
Recent Filings · Page 4 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-09-03 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | −50,000 | -$2.09M | EDGAR |
| 2013-06-18 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +8,358 | -$60.0K | EDGAR |
| 2013-06-11 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-14 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +4,876 | -$19.9K | EDGAR |
| 2013-03-20 | — | Buy (P) | +11,111 | $100.0K | |
| 2013-03-04 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +7,059 | -$25.2K | EDGAR |
| 2013-03-01 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +12,342 | -$43.8K | EDGAR |
| 2013-02-26 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +7,465 | -$26.6K | EDGAR |
| 2013-02-20 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +13,586 | -$50.2K | EDGAR |
| 2012-08-14 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.